Sentences with phrase «company sequenced the human genome»

An Animated History of Reproduction Part cloning experiment, part documentary, Stories from the Genome follows an unnamed CEO - geneticist whose company sequenced the Human Genome in 2003 — a genome that secretly was his own.

Not exact matches

Venter, who is one of the first people to sequence the human genome, co-founded the company in effort to discover early genetic markers for a variety of disorders.

Just last month, the genomic sequencing company Illumina announced it had developed a genome sequencer that can map the human genome for just $ 1,000.

The move comes in response to the announcement earlier this week of a new U.S. company, launched by sequencing - machine manufacturer Perkin - Elmer and J. Craig Venter of The Institute for Genomic Research, that plans a brute - force approach to sequencing the human genome within 3 years (ScienceNOW, 12 May).

«Sequencing the human genome, device miniaturization, and the advent of combination devices have shifted the focus from engineering to the life sciences in the device industry,» adds Jules Mitchel, president of Target Health Inc. in New York City, a company that conducts clinical trials for MD&D companies.

Over the next year, the company plans to use data from human genomes sequenced with its new machines to develop the statistics needed to evaluate how accurate the data are.

The biggest expense in sequencing a human genome now is the cost of storing it, says Scott Kahn, chief information officer of Illumina, a San Diego biotech company specializing in high - throughput sequencing.

The company's thermal cyclers were used by every major genome centre during the sequencing of the human genome and were most recently used by the BC Cancer Agency during the sequencing of the SARS virus.

Venter is now CEO of a company called Human Longevity Inc. that aims to sequence 1 million participants» genomes by 2020 — a new private competitor to Collins's federal cohort study, perhaps.

The company, Human Genome Sciences Inc. (HGS) in Rockville, Maryland, found the gene by sequencing human DNA and searching databases for possible genes; it didn't know there was a link to AIDS when it filed a patent application in Human Genome Sciences Inc. (HGS) in Rockville, Maryland, found the gene by sequencing human DNA and searching databases for possible genes; it didn't know there was a link to AIDS when it filed a patent application in human DNA and searching databases for possible genes; it didn't know there was a link to AIDS when it filed a patent application in 1995.

Using the new technology, Complete Genomics» chief scientist Radoje Dramanac estimates that the company will soon be able to sequence a complete human genome in about a day.

He says HGS was getting «diminishing returns» from its investment in TIGR since Venter had steered his outfit into sequencing organisms of little medical importance, and into human genome sequencing, also of limited value for a company like HGS that is interested in genes as drug targets (not untranslated DNA that makes up most of the genome).

Complete Genomics, a Mountain View, California - based biotechnology company last year claimed it would soon be able to sell full human genome sequences for as little as $ 5000 apiece.

Following this path, Rothberg says the company will be able to sequence complete human genomes for $ 1000 by 2013: «It's so scalable... the $ 1000 genome is inevitable.»

That all changed in the late 1990s, when Craig Venter's private company Celera and the publicly funded Human Genome Project competed to see who could finish the first complete genome seqGenome Project competed to see who could finish the first complete genome seqgenome sequence.

Using its proprietary sequencing instruments, chemistry, and software, the company has sequenced more than 20,000 whole human genomes.

Similarly, biomedical and pharmaceutical research is bedazzled by molecular genetics, has sequenced the genome of one or two humans and a handful of other species and invested trillions on very rigidly reductionistic bottom - up research into medicines and diseases — with the result of empty drug pipelines for the big pharma companies in spite of all this investment.

The next twelve years of his career he spent in in - house positions of increasing responsibility, at companies to include Merck & Co., Inc., Genetics Institute, Inc. and Wyeth Pharmaceuticals, Inc.Werten completed his in - house career with Celera Genomics (NYSE: CRA), the biotechnology company located in Rockville, Maryland and credited with sequencing the human genome.